SynthesisFrontiers in cardiovascular medicine2025

Effectiveness of combining PCSK9 inhibitors with statins on major adverse cardiovascular events and lipid levels in patients after percutaneous coronary intervention: a systematic review and meta-analysis.

Zhantao Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.